Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2021
Reporting Period: Quarterly period ended June 30, 2021
This filing serves as a notification that the company issued a press release on August 5, 2021, announcing its financial results for the quarter ended June 30, 2021. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing states that the detailed results are contained in the attached press release (Exhibit 99.1). Consequently, the following metrics are not available in this text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These disclosures are expected to be found within the referenced press release.
Important Facts for Investor Verification
- Source of Data: The actual financial numbers and operational updates are located in Exhibit 99.1 (Press Release dated August 5, 2021), not in the body of this 8-K.
- Reporting Period: Verify that the data in the press release corresponds to the quarter ended June 30, 2021.
- Trading Symbol: Common stock trades on the NASDAQ Global Select Market under the symbol "COLL".
- Emerging Growth Status: The filing indicates the company is not checking the box for "Emerging growth company" status in this specific form.